After a surprise washout in a…
After a surprise washout in a recent phase 3 trial [...]
The FDA has approved Takeda’s…
The FDA has approved Takeda’s Mimrylo (rusfertide) for polycythemia vera, [...]
In their high-profile competition…
In their high-profile competition in the diabetes and obesity markets, [...]
Biogen highlighted patient…
Biogen highlighted patient advocate and content creator Naomi Rose’s story [...]
Omnicom’s maslansky + partners…
Omnicom’s maslansky + partners has expanded its leadership team, hiring [...]
Stephen Farquhar has taken over as…
Stephen Farquhar has taken over as CEO of Publicis Health [...]
Though not without a bump along…
Though not without a bump along the way, Roivant-backed Priovant [...]
Roche is taking a less-trodden…
Roche is taking a less-trodden path in obesity. Akeso CEO [...]
Ajaz Khan, M.D., a medical…
Ajaz Khan, M.D., a medical oncologist at City of Hope [...]
In the latest in a string of…
In the latest in a string of setbacks in biopharma’s [...]